100 studies found for:    CELIAC DISEASE
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Antibody Treatment for Advanced Celiac Disease
Conditions: Celiac Disease;   Celiac Sprue;   Gluten Enteropathy;   Gluten-Sensitive Enteropathy
Intervention: Biological: Hu-Mik- Beta-1
2 Recruiting Detection of Celiac Disease in Patients With Hypothyroidism
Conditions: Celiac Disease;   Hypothyroidism;   Celiac Sprue;   Malabsorption
Intervention:
3 Completed Safety Study of Nexvax2 in Subjects With Coeliac Disease
Conditions: Coeliac Disease;   Celiac Disease
Interventions: Biological: 9 micrograms Nexvax2;   Biological: 30 micrograms Nexvax2;   Biological: 90 micrograms Nexvax2;   Biological: 60 micrograms Nexvax2;   Biological: Up to 900 micrograms Nexvax2;   Other: Placebo
4 Completed Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Condition: Celiac Disease
Intervention:
5 Recruiting Celiac Disease and Diabetes- Dietary Intervention and Evaluation Trial
Conditions: Celiac Disease;   Diabetes Mellitus, Type 1
Intervention: Dietary Supplement: Gluten Free Diet
6 Recruiting Oral AGY for Celiac Disease
Condition: Celiac Disease
Intervention: Other: AGY
7 Completed Safety and Efficacy of ALV003 for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Biological: ALV003;   Biological: ALV003 placebo
8 Completed Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Biological: ALV003;   Biological: ALV003 placebo
9 Not yet recruiting Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Conditions: Celiac Disease;   Iron Deficiency;   Iron Malabsorption
Intervention:
10 Completed A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Drug: Larazotide Acetate 0.5 mg;   Drug: Larazotide Acetate 1 mg;   Drug: Larazotide Acetate 2 mg;   Drug: placebo
11 Completed Treatment of Mild Enteropathy Celiac Disease
Condition: Celiac Disease
Intervention: Dietary Supplement: Gluten-free diet
12 Recruiting Impact of the Diagnosis of Celiac Disease
Condition: Celiac Disease
Intervention:
13 Recruiting Immune Response in Celiac Disease on In-vitro Gluten Challenge
Condition: Celiac Disease
Intervention:
14 Recruiting Celiac Disease Database
Condition: Celiac Disease
Intervention:
15 Recruiting Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
Condition: Celiac Disease
Interventions: Drug: ALV003;   Drug: placebo
16 Completed Treatment of Screen-detected Celiac Disease
Condition: Celiac Disease
Intervention: Dietary Supplement: Gluten-free diet
17 Completed Protocol for Correlating Enteropathic Severity and Small Intestinal CYP3A4 Activity in Patients With Celiac Disease
Condition: Celiac Disease
Intervention: Drug: Simvastatin
18 Unknown  Study of Enzyme Supplements to Treat Celiac Disease
Conditions: Celiac Disease;   Dermatitis Herpetiformis
Interventions: Drug: STAN1;   Drug: Placebo enzyme;   Drug: STAN1+gluten
19 Active, not recruiting Celiac Disease Prevention
Condition: Celiac Disease
Intervention: Other: Optimal gluten introduction
20 Recruiting Celiac Disease Genomic Environmental Microbiome and Metabolomic Study
Condition: Celiac Disease
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years